• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

每周监督口服抗精神病药物治疗:长效注射的替代方案?

Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?

机构信息

Lisbon's Psychiatric Hospitalar Centre, Avenida do Brasil 53, 1749, Lisbon, Portugal.

Legismente, Forensic Psychiatry and Psychology, Rua Conde de Redondo, nº 8 3º dt., 1150, Lisbon, Portugal.

出版信息

CNS Drugs. 2022 Apr;36(4):315-325. doi: 10.1007/s40263-022-00906-4. Epub 2022 Feb 28.

DOI:10.1007/s40263-022-00906-4
PMID:35226350
Abstract

Maintenance of response in schizophrenia is largely dependent on compliance with antipsychotic treatment. When people with schizophrenia are responsible for their own treatment, partial or non-adherence is common and usually results in relapse. Assured compliance with antipsychotic treatment is possible when long-acting injectable antipsychotics are given by healthcare staff, but some patients may not consent to treatment for a variety of reasons. An alternative to long-acting injections is the use of supervised oral administration of long-acting antipsychotics. This method assures compliance with prescribed regimens without the need for injections. To be suitable for once-weekly administration as an oral formulation, an antipsychotic needs to have a sufficiently long duration of action and to be well tolerated in high doses. There is evidence that weekly oral administration of either pimozide or penfluridol is effective and well tolerated in the treatment of schizophrenia. Other drugs potentially suitable for once-weekly oral administration include aripiprazole, brexpiprazole and cariprazine.

摘要

精神分裂症的疗效维持在很大程度上取决于患者对精神药物治疗的依从性。当精神分裂症患者负责自己的治疗时,部分或不依从的情况很常见,通常会导致病情复发。当医护人员给患者使用长效注射抗精神病药时,可以确保其依从性,但出于各种原因,有些患者可能不同意接受治疗。长效注射的替代方法是使用监督下口服长效抗精神病药。这种方法可以确保患者遵守规定的治疗方案,而无需注射。为了适合每周一次的口服给药,抗精神病药需要具有足够长的作用持续时间,并且能够耐受高剂量。有证据表明,每周口服匹莫齐特或奋乃静治疗精神分裂症是有效且耐受良好的。其他可能适合每周一次口服给药的药物包括阿立哌唑、布瑞哌唑和卡利拉嗪。

相似文献

1
Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?每周监督口服抗精神病药物治疗:长效注射的替代方案?
CNS Drugs. 2022 Apr;36(4):315-325. doi: 10.1007/s40263-022-00906-4. Epub 2022 Feb 28.
2
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.长效注射用抗精神病药物治疗精神分裂症:文献综述与实践视角,重点关注阿立哌唑每月一次注射剂
Adv Ther. 2017 May;34(5):1036-1048. doi: 10.1007/s12325-017-0507-x. Epub 2017 Apr 5.
3
Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.阿立哌唑每月一次治疗英国精神分裂症的成本效益分析。
J Ment Health Policy Econ. 2015 Dec;18(4):185-200.
4
Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study.阿立哌唑长效注射剂治疗患者的临床演变:一项初步的、前瞻性、观察性研究。
Int J Psychiatry Clin Pract. 2020 Mar;24(1):10-17. doi: 10.1080/13651501.2019.1711130. Epub 2020 Jan 14.
5
Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.阿立哌唑每月一次长效注射剂用于治疗精神分裂症。
Expert Opin Pharmacother. 2016;17(3):395-407. doi: 10.1517/14656566.2015.1114100.
6
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析:长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
7
Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.在稳定使用非阿立哌唑的特定非典型口服抗精神病药物的精神分裂症成人患者中,起始每月一次阿立哌唑治疗的安全性和耐受性。
Curr Med Res Opin. 2013 Oct;29(10):1241-51. doi: 10.1185/03007995.2013.821973. Epub 2013 Jul 25.
8
Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study.长效注射用抗精神病药阿立哌唑劳洛昔康 2 个月给药间隔方案的药代动力学、安全性和耐受性:一项 44 周 I 期研究的结果。
CNS Drugs. 2020 Sep;34(9):961-972. doi: 10.1007/s40263-020-00745-1.
9
Initiation of aripiprazole once-monthly in patients with schizophrenia.精神分裂症患者每月一次阿立哌唑的起始治疗。
Curr Med Res Opin. 2015 Mar;31(3):583-92. doi: 10.1185/03007995.2015.1006356. Epub 2015 Feb 5.
10
Long-acting injectable antipsychotics in the elderly: guidelines for effective use.老年患者长效注射用抗精神病药物:有效使用指南
Drugs Aging. 2003;20(15):1099-110. doi: 10.2165/00002512-200320150-00003.

本文引用的文献

1
Bioequivalence of 2 Aripiprazole Orally Disintegrating Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.两种阿立哌唑口腔崩解片在健康中国志愿者空腹和进食条件下的生物等效性。
Clin Pharmacol Drug Dev. 2021 Aug;10(8):840-849. doi: 10.1002/cpdd.954. Epub 2021 Jun 8.
2
The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study.抗精神病药物剂型对精神分裂症患者停药时间的影响:一项荷兰登记处基于回顾性队列研究。
CNS Drugs. 2021 Apr;35(4):451-460. doi: 10.1007/s40263-021-00802-3. Epub 2021 Apr 10.
3
Population Pharmacokinetics of Cariprazine and its Major Metabolites.
卡利拉嗪及其主要代谢物的群体药代动力学。
Eur J Drug Metab Pharmacokinet. 2021 Jan;46(1):53-69. doi: 10.1007/s13318-020-00650-4.
4
Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia.使用长效注射用抗精神病药提高精神分裂症的康复潜力。
J Clin Psychiatry. 2020 Jun 30;81(4):MS19053AH5C. doi: 10.4088/JCP.MS19053AH5C.
5
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).对全国范围内62250例精神分裂症患者队列(FIN20)进行的关于抗精神病药物治疗与身体发病率和死亡率关系的20年随访研究。
World Psychiatry. 2020 Feb;19(1):61-68. doi: 10.1002/wps.20699.
6
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses.抗精神病药物治疗精神分裂症的急性疗效:近期荟萃分析综述
Ther Adv Psychopharmacol. 2018 Oct 8;8(11):303-318. doi: 10.1177/2045125318781475. eCollection 2018 Nov.
7
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?精神分裂症患者长期使用抗精神病药物治疗的风险效益比是多少?
World Psychiatry. 2018 Jun;17(2):149-160. doi: 10.1002/wps.20516.
8
Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia.多次给药后布雷哌嗪在日本精神分裂症患者中的药代动力学及安全性
J Clin Pharmacol. 2018 Jan;58(1):74-80. doi: 10.1002/jcph.979. Epub 2017 Jul 27.
9
Medication adherence in schizophrenia.精神分裂症患者的药物依从性。
World J Psychiatry. 2012 Oct 22;2(5):74-82. doi: 10.5498/wjp.v2.i5.74.
10
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.首发精神病停药后症状复发的风险:系统综述。
Schizophr Res. 2014 Feb;152(2-3):408-14. doi: 10.1016/j.schres.2013.08.001. Epub 2013 Aug 21.